TREAT: Translational Research in Alcohol Treatment

🚀Applications Now Open: Fully-Funded PhD Opportunity at the Forefront of Neuroscience-Informed Addiction Treatment Find out more here: linkedin.com/jobs/view/4293…

Professor @Dan_Lubman recently had the opportunity to join @TheFlorey's podcast, The Brain Matters, to explore addiction - what it is, how it develops and how neuroscience can inform treatment. Listen wherever you get your podcasts, or on Spotify: bit.ly/401V9CB

A study comparing topiramate with naltrexone found topiramate to be at least as effective and safe as the first-line medication naltrexone in reducing heavy alcohol consumption and superior in reducing some clinical outcomes. @DrKirstenMorley bit.ly/3wV1NQA

What does science say about alcohol addiction? Prof Andrew Lawrence, Head of our Addiction Neuroscience Group, spoke with @theheraldsun about the importance of destigmatising addiction and defining it as a medical condition. Read here: florey.edu.au/news/2024/09/t… #TheFlorey

A group of experts in addiction from @MonashAddiction is presenting this week at the 2024 World Congress on Alcohol & Addictions in Melbourne. @ISBRAComm Looking forward to hearing about the discussions with the world's leading experts in this field. + isbra2024.com

📸 Today, our Addiction Neuroscience Group is attending the 2024 World Congress on Alcohol and Addictions at Melbourne Convention and Exhibition Centre. We're ready for some great discussions with the world's experts in this space: isbra2024.com @ISBRAComm #TheFlorey

Help us characterise individuals living with alcohol use disorder in the community. If you meet the following criteria, we would like to hear from you! - Alcohol consumption exceeds the Aus guidelines - 18 + years - Living in Australia Click here: shorturl.at/5P8kN

When Gene* was offered the chance to participate in a trial investigating a promising new antioxidant that could help people reduce their alcohol intake, he was keen to sign up. Read about Gene’s experiences, including the medical support he received: turningpoint.org.au/about-us/news/…

Head to head genotype-stratified trial of topiramate vs naltrexone! Topiramate was as effective and safe as naltrexone, but superior on some outcomes. There were no sig effects of rs2832407 nor rs1799971 @AlcoholSynergy @SydneyResearch @syd_health ajp.psychiatryonline.org/doi/abs/10.117…

Find out more about the @AlcoholSynergy team’s work investigating new pharmacological targets treat-alcohol.com

Can a drug like Ozempic help treat addictions to alcohol, opioids or other substances? @AlcoholSynergy experts @SArunogiri @LeighWalkerPhD & Roberta Goncalves explore their rise, impact and potential consequences in @ConversationEDU tinyurl.com/249bcrz9

Come work with us! Interested in addiction treatment research? Keen on clinical trials, neuroscience, neuropharmacology and/or neuropsychology? Join our NHMRC Synergy research program! @Edith__Collins @gavanm @dan_lubman @SArunogiri @drvictoriamann1 tinyurl.com/2p8ujbwz

Great opportunity for #postdoc position in #alcohol #neuroscience working with a fantastic interdisciplinary team @SOBRNetwork @Postdocjobsaus @TheFlorey @AlcoholSynergy